BRCA1, BRCA2, and TP53 germline and somatic variants and clinicopathological characteristics of Brazilian patients with epithelial ovarian cancer

Documenti analoghi

• Factors affecting the implementation of cascade testing of patients with BRCA1 or BRCA2 pathogenic germline variants in Japan
  di: Yoshimi Kiyozumi, et al.
  Pubblicazione: (2025)
• Featuring BRCA1 and BRCA2 germline mutational landscape from Asturias ( North Spain )
  di: Ana S. Pitiot, et al.
  Pubblicazione: (2024)
• Correction to “Mutation spectra of the BRCA1 /2 genes in human breast and ovarian cancer and germline”
  Pubblicazione: (2024)
• Pre-test prediction models of BRCA1 or BRCA2 mutation in breast/ovarian families attending familial cancer clinics
  di: de la Hoya, M, et al.
  Pubblicazione: (2003)
• Correlation between the number of false positive variants and the quality of results using Ion Torrent PGM™ sequencing to screen BRCA genes
  di: Tiago César Gouvêa Moreira
  Pubblicazione: (2021)